Australian pharmaceutical company CSL says it's completed adult clinical trial of avian influenza vaccine
-
Last Update: 2020-07-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Australian pharmaceutical company CSL has announced the success of clinical trials of avian influenza vaccines in adults and says it will be able to vaccinate 20 million people across Australia if necessaryCSL has developed the avian influenza vaccine with funding from the Australian GovernmentCSL says it will be the first bird flu vaccine registered in the southern hemisphere and will be available to Asian countries laterCSL spokeswoman Rachel Davey said: "We are now focusing on the Indonesian and Vietnamese strains currently raging in the region and we should be able to vaccinate the Australian population within the next six months."The company's clinical trials showed that, within three weeks, two doses of 30 milligrams were given to adults between the ages of 16 and 65, and they would have a strong antibody to the highly lethal H5N1 avian influenza virusThe results of trialsinfants, young children and the elderly will be released later this year, David saidEarlier this week, CSL's rival GlaxoSmithKline announced that its bird flu vaccine had achieved an 80 per cent success rate in clinical trials and had been approved to register in Europe(rereproduced from Singapore Morning Post)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
